Edgestream Partners’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Edgestream Partners's HALO Position: Q2 2026 in Review
Edgestream Partners reduced its Halozyme (HALO) stake by 3.4% in Q2 2026, selling an estimated $117K and leaving 49,411 shares worth $3.87M. The position accounts for 0.11% of the portfolio, ranked #332.
Edgestream Partners first reported a position in HALO in Q3 2022 and has held it in 15 quarters since. The position peaked at $8.64M in Q1 2025. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Edgestream Partners held 49,411 shares of Halozyme worth $3.87M as of Q2 2026.
- Edgestream Partners sold 1,713 Halozyme shares in Q2 2026, an estimated $117K.
- Halozyme made up 0.11% of Edgestream Partners's portfolio in Q2 2026, its #332 holding.
- Edgestream Partners first reported a position in Halozyme in Q3 2022 and has held it in 15 quarters since.
- Edgestream Partners's Halozyme position peaked at $8.64M in Q1 2025.
- 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.